COVID-19 and clinical trials
dc.date.accessioned | 2024-07-12T21:58:29Z | |
dc.date.available | 2024-07-12T21:58:29Z | |
dc.date.issued | 2021 | en_US |
dc.department | Maltepe Üniversitesi, Rektörlük | en_US |
dc.description.abstract | Introduction: Covid-19 pandemics has become a topic of concern to the whole world. There are thousands of ongoing studies around the world to overcome the burden. Interventional clinical trials; a type of clinical study, is an important source of clinical evidence. Evidence-based data will promote be er treatment for Covid-19 patients. Aim: In the study, we aimed to explore the latest numbers of clinical studies and interventional studies on Covid-19. We further explored the ratios of completed studies and distribution among countries to better understand the landscape of clinical studies on Covid-19. Methods: The database “clinicaltrial.gov” is used to retrieve clinical studies that are conducted around the world until 03.05.2021. The number of clinical studies according to study type, status, and distribution among countries are analyzed. Results and Discussion: Total of 5.550 Covid-19 clinical trials are found in the database and; status of 1.037 trials recorded as completed. Out of 5.550 clinical trials, 3.121 trials (56%) are within the interventional clinical trial category. 464 of them completed. On the other hand, out of a total 1.461 are recorded as recruiting drug trials. Most interventional clinical trials are recorded in North America, United States and Europe. While 15 trials are coming from Canada, North America is the region that has the most studies with 164 interventional trials. Furthermore, in North Asia, 31 trials exist and 27 of 31 belong to Russian Federation. Also, 33 of the studies that completed in Europe are in France, 22 of them are in the United Kingdom, so the total number of interventional trials in Europe is 120. If we had a look at Turkey has 27 trials. Finally, SARS-CoV-2 has affected the whole world and we still need more evidence to better treat the patients. | en_US |
dc.identifier.citation | Erdem, S.R. (2021). COVID-19 and clinical trials. International Faculty of Medical Sciences and Nursing(MEDNS) Student Congress, Maltepe Üniversitesi. s. 44-45. | en_US |
dc.identifier.endpage | 45 | en_US |
dc.identifier.isbn | 978-605-2124-39-0 | |
dc.identifier.startpage | 44 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12415/8813 | |
dc.institutionauthor | Erdem, Sevde Rana | |
dc.language.iso | en | en_US |
dc.publisher | Maltepe Üniversitesi | en_US |
dc.relation.ispartof | International Faculty of Medical Sciences and Nursing(MEDNS) Student Congress | en_US |
dc.relation.publicationcategory | Uluslararası Konferans Öğesi - Başka Kurum Yazarı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.snmz | KY08061 | |
dc.subject | COVID-19 | en_US |
dc.subject | clinical studies | en_US |
dc.subject | interventional clinical trial | en_US |
dc.title | COVID-19 and clinical trials | en_US |
dc.type | Conference Object | |
dspace.entity.type | Publication |